Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 22, 2021Cancer Biotherapy and Radiopharmaceuticals

Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMarcel C. LangenbachTVThomas J. VoglGSGulia Said

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Langenbach et al. (2021) studied this question.

synapsesocial.com/papers/6a6fa87f5d37378ac1dcb6bahttps://doi.org/10.1089/cbr.2020.4137
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid‐enhanced MRI: Comparison with multiphasic multidetector computed tomography2016 · 76 citations
  2. 2Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT2005 · 30 citations
  3. 3Hypervascular Hepatocellular Carcinoma: Can Double Arterial Phase Imaging with Multidetector CT Improve Tumor Depiction in the Cirrhotic Liver?2002 · 99 citations
  4. 4Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings2017 · 87 citations